Another AAP MLA arrested by Delhi police

Mangaluru, May 23: Domestic flight services will resume from Mangaluru International Airport (MIA) from May 25 as per the instructions of Union Civil Aviation Ministry. Six Indigo and SpiceJet flights will be operated from Mangaluru to Bengaluru, Mumbai and Chennai.

Air-India is yet to finalise its schedule, airport sources said. Three Indigo flights will depart from Mangaluru to Bengaluru, Mumbai and Chennai and three flights of SpiceJet will leave for Bengaluru and Mumbai on May 25.

SpiceJet flight will take off from Bengaluru to Mangaluru at 8.30 am and7 pm while Indigo will take off from Mangaluru to Bengaluru at 5.55 pm. SpiceJet flight will take off from Mangaluru at 10.20 am and 9.35 pm while Indigo will depart at 7.30 pm.

From Mumbai, Spice Jet flight will take off at 7.05 am and Indigo at 9.30 am. The Mangaluru-Mumbai SpiceJet flight will take off at 9.05 am and Indigo at 11.40 am. Indigo flight will depart from Chennai to Mangaluru at 5.45 pm and from Mangaluru to Chennai at 8.05 am.

Saharanpur (Uttar Pradesh), May 19: Islamic seminary Darul Uloom Deoband has issued a fatwa asking Muslims to offer their Eid prayers this time at home, instead of congregating at mosques.

The directive comes amid a nationwide lockdown to slow down the spread of coronavirus.

Despite the relaxations announced in the lockdown, religious and other large gatherings are still banned.

The fatwa was issued in response to a query put to the seminary, its spokesman Ashraf Usmani said.

The fatwa said the Eid namaz can be offered in the same manner that the Friday prayers are now being read at home.

It said not holding the namaz in the usual manner is pardonable in circumstances such as these.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.